Welcome to OneVax, LLC

Bridging Biomaterials and Immunology to Cure Autoimmune Diseases

Executive OFficers

Meet the OneVax, LLC Founders and Advisors

OneVax Scientists

Meet the OneVax, LLC Scientists

Sid Martin Institute

World-recognized Leader in Biotechnology Business Incubation

Arrow
Arrow
Slider

About Us

OneVax, LLC is a pre-clinical biotechnology company located in Alachua, Florida developed to harness the intellectual and research advances of University of Florida faculty for applications in the advancement of human health, and specifically, type 1 diabetes. Members of the UF Diabetes Institute and the Department of Biomedical Engineering constitute the core membership and provide the scientific direction of the company. The initial business interests of the company involve the development of novel vaccine formulations that incorporate biomaterials and polymers for applications including multicomponent and time-release drug delivery.  The core goal of OneVax is to harness our knowledge of the immune system and biomaterials to create a tolerogenic vaccine to prevent and/or reverse type 1 diabetes.